Earnings ·
Mesa Laboratories reported first-quarter fiscal 2027 results for the period ended June 30, 2026
MLABMesa Laboratories Inc
Mesa Laboratories reported first-quarter fiscal 2027 results for the period ended June 30, 2026. Total revenues increased 1.0% to $60.1 million, with non-GAAP adjusted operating income rising 19.5% to $15.4 million excluding unusual items. The company repaid $8.7 million in debt, reducing its total net leverage ratio to 1.85. Net income decreased 40.3% to $2.8 million due to nonoperating expenses and foreign currency gains in the prior year period. A legal settlement of $382,000 was recorded as an unusual item. The company operates in the life science tools and quality control solutions industry.